Nilotinib, a drug approved by the US Food and Drug Administration (FDA) to treat chronic myeloid leukemia, improved ...

Detailed price information for Annovis Bio Inc (ANVS-N) from The Globe and Mail including charting and trades.

The company is currently advancing its lead candidate, CT1812, in clinical programs targeting Alzheimer’s disease, dementia with Lewy bodies, and dry age-related macular degeneration. In its third ...

CT1812 slowed cognitive decline by 95% in Alzheimer’s disease patients with lower levels of plasma p-tau217 in a pre-specified analysis from ...

Deaths from dementia included deaths from conditions such as vascular dementia, unspecified dementia, Alzheimer’s disease and ...

Ted Turner's colorful life is chronicled over six episodes on Max in a docuseries dubbed "Call Me Ted" out Nov. 13, 2024.

Lewy body dementia (LBD) is a progressive neurodegenerative disease that shares traits with both Parkinson's disease and Alzheimer's disease but can be more difficult to diagnose. Lewy bodies ...

According to his autopsy, Williams had diffuse Lewy bodies, which contributed to the severity of his depression and anxiety.

Protein deposits in nerve cells cause dementia with Lewy bodies (DLB). These deposits interrupt chemical messages in the brain, causing memory loss and disorientation. People may also refer to DLB ...

Nilotinib (Tasigna) — a drug for myeloid leukemia — improved biomarkers and cognitive outcomes in study participants with dementia with Lewy bodies, a new study finds.